Clinical Trial Update: A Pilot Trial of Citicoline in Individuals With Mild Traumatic Brain Injury (mTBI) [Phase 2]

View source ↗

Summary

A Phase 2 pilot trial of Citicoline for mild traumatic brain injury has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Traumatic Brain Injury

Drugs mentioned

• Citicoline (CDP-choline)

Snippet

Sponsor: Mclean Hospital | Conditions: Traumatic Brain Injury | Phase 2 | Status: WITHDRAWN